Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men

Fertility and Sterility

Volumn 81, Issue 3, 2004, Pages 595-604

  Acacio, Brian D ^b   Stanczyk, Frank Z ^b   Mullin, Patrick ^b   Saadat, Payam ^b   Jafarian, Neda ^b   Sokol, Rebecca Z ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Androgens; Androstenedione; Dehydroepiandrosterone (DHEA); Dehydroepiandrosterone sulfate (DHEAS); E2, dihydrotestosterone (DHT), 5 androstane 3 ,17 diol glucuronide (ADG); Male

Indexed keywords

ANDROSTANEDIOL GLUCURONIDE; ANDROSTANOLONE; ANDROSTENEDIONE; ANDROSTERONE DERIVATIVE; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; PLACEBO; PRASTERONE; PRASTERONE SULFATE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LONG TERM CARE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE GENITAL SYSTEM; NORMAL HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; SEMEN ANALYSIS; UNITED STATES;

ADMINISTRATION, ORAL; ADULT; ANDROSTANE-3,17-DIOL; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DIHYDROTESTOSTERONE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; REFERENCE VALUES;

EID: 1642277861     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.07.035     Document Type: Article

References (39)

1. Mortola J.F., Yen S.S.C. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 71:1990;696-704.
2. Khorram O. DHEA a hormone with multiple effects. Curr Opin Obstet Gynecol. 8:1996;351-354.
3. Skolnick A.A. Scientific verdict still out on DHEA. JAMA. 276:1996;1365-1367.
4. Armsey T.D., Green G.A. Nutrition supplements science vs. hype. Phys Sports Med. 25:1997;77-116.
5. Ravaglia G., Forti P., Maioli F., Boschi F., Bernardi M., Pratelli L., et al. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab. 81:1996;1173-1178.
6. Watson R.R., Huls A., Araghinikuam M., Chung S. Dehydroepiandrosterone and diseases of aging. Drugs Aging. 9:1996;274-291.
7. Barrou Z., Charru P., Lidy C. Dehydroepiandrosterone (DHEA) and aging. Arch Gerontol Geriatr. 24:1997;233-241.
8. Khaw K.T. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. J Endocrinol. 150:1996;S149-153.
9. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Raum W.J., et al. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry. 41:1997;311-318.
10. Rubinstein M.L., Federman D.G. Sports supplements. Can dietary additives boost athletic performance and potential? Postgrad Med. 108:2000;103-112.
11. Buster J.E., Casson P.R. DHEA: biology and use in therapeutic intervention. Lobo R.A., Kelsey J., Marcus R. Menopause: biology and pathobiology. 2000;625-637 Academic Press, New York.
12. Willemse P.H.B., Dikkeschei L.D., Wolthers B.G. Physiological importance of dehydroepiandrosterone. Lancet. 344:1994;483-484.
13. Longcope C. Dehydroepiandrosterone metabolism. J Endocrinol. 150:(Suppl):1996;S125-127.
14. Labrie F., Belanger A., Cusan L., Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites intracrinology. J Clin Endocrinol Metab. 82:1997;2403-2409.
15. Haning R.V. Jr, Flood C.A., Hackett R.J., Loughlin J.S., McClure N., Longcope C. Metabolic clearance rate of dehydroepiandrosterone sulfate, its metabolism to testosterone, and its intrafollicular metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone in vivo. J Clin Endocrinol Metab. 72:1991;1088-1095.
16. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:1984;551-555.
17. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 78:1994;1360-1367.
18. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., Yen S.S.C. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf). 49:1998;421-432.
19. Yen S.S.C., Morales A.J., Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci. 774:1995;128-142.
20. th ed:1997;547-566 Blackwell Science, Malden.
21. Sokol R.Z., Palacios A., Campfield L.A., Saul C., Swerdloff R.S. Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men. Fertil Steril. 37:1982;425-430.
22. 2. Prostate. 26:1995;325-333.
23. Siiteri P.K., Wilson J.D. Dihydrotestosterone in prostatic hypertrophy. 1. The formation and content of dihydrotesterone in the hypertrophic prostate of man. J Clin Invest. 49:1970;1737-1745.
24. World Health Organization. Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 3d ed. 1993;3-13 Cambridge University Press, New York.
25. Lobo R.A., Goebelsmann U., Brenner P.F., Mishell D.R. Jr. The effects of estrogen on adrenal androgens in oophorectomized women. Am J Obstet Gynecol. 142:1982;471-478.
26. Goebelsmann U., Horton R., Mestman J.H., Arce J.J., Nagata Y., Nakamura R.M., et al. Male pseudohermaphroditism due to testicular 17β- hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 36:1973;867-879.
27. Serafini P., Ablan F., Lobo R.A. 5α-Reductase activity in the genital skin of hirsute women. J Clin Endocrinol Metab. 60:1985;349-355.
28. Lobo R.A., Paul W.L., Goebelsmann U. Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function. Obstet Gynecol. 57:1981;69-73.
29. SAS Institute Inc. SAS/STAT user's guide. Ver. 6.03. 1988;SAS Institute, Cary, N.C.
30. Flynn M.A., Weaver-Osterholtz D., Sharpe-Timms K.L., Allen S., Krause G. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab. 84:1999;1527-1533.
31. Ballantyne C.S., Phillips S.M., MacDonald J.R., Tarnopolsky M.A., MacDougall J.D. The acute effects of androstenedione supplementation in healthy young males. Can J Appl Physiol. 25:2000;68-78.
32. Leder B.Z., Longcope C., Catlin D.H., Ahrens B., Schoenfeld D.A., Finkelstein J.S. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA. 283:2000;779-782.
33. Brown G.A., Vukovich M.D., Martini E.R., Kohut M.L., Franke W.D., Jackson D.A., et al. Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men. J Clin Endocrinol Metab. 85:2000;4074-4080.
34. Paulson R.J., Serafini P.C., Catalino J.A., Lobo R. Measurement of 3α,17β androstanediol glucuronide in serum and urine and the correlation with skin 5α-reductase activity. Fertil Steril. 46:1986;222-226.
35. Slater CC, Zhang C, Guan C, Huang R, Paulson RJ, Roy S, et al. Dihydrotestosterone (DHT) accumulation as a consequence of long-term DHEA supplementation in postmenopausal women [abstract no. 0-10]. Fertil Steril 2000;79(Suppl 1):7S-8
36. Ebeling P., Koivisto V.A. Physiological importance of dehydroepiandrosterone. Lancet. 343:1994;1479-1481.
37. Horton R. Testicular steroid transport, metabolism and effects. Becker K.L. Principles of endocrinology and metabolism. 2d ed:1995;1042-1047 J.B. Lippincott Co, Philadelphia.
38. Hinman F. Jr. Screening for prostatic carcinoma. J Urol. 145:1991;126-130.
39. Jin B., Turner L., Walters W.A., Handelsman D.J. The effects of chronic high dose androgen or estrogen treatment on the human prostate. J Clin Endocrinol Metab. 81:1996;4290-4295.